PRKCA and chondrosarcoma: The early onset chondrosarcomas associated with the heterozygous knock-in of the penetrant chordoid glioma-associated PRKCA D463H mutation in mice and the lack of any phenotype associated with the related D463N mutant knock-in suggests that this mutation confers an in vivo gain-of-function.